antidepressant

Otsuka
Marketing

FDA rules key Otsuka marketing claim overstates Rexulti efficacy

Otsuka has repeatedly said its product reduces depression symptoms 62% more than the antidepressant alone, but the FDA found no basis for the figure.
Nick Paul Taylor Nov 13, 2023 8:05am
Financial and business background for Stacking of money coins-stock photo Mongkol OnnuanGetty Images

Axsome to add nearly 100 Auvelity sales reps to workforce

Nov 6, 2023 12:05pm
A screenshot from Bauschs Looking Forward campaign

Bausch starts first TV campaign for seasonal depression drug

Oct 27, 2023 9:20am
A puzzle of the brain with one missing piece

Depression med Exxua finally cleared by FDA after 2-plus decades

Sep 28, 2023 6:11pm